Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$134,849,568
New position
Shares Held
683,752
first reported quarter
Ownership
0.044%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $2,568,983,951 across 16 Drug Manufacturers - General names. AZN ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
767,347 | $705,782,748 | |
| 2 | JNJ |
Johnson & Johnson
|
1,961,422 | $479,449,993 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,102,456 | $252,904,431 | |
| 4 | ABBV |
AbbVie Inc.
|
884,601 | $192,391,870 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,158,099 | $161,404,257 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
683,752 | $134,849,568 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,199,004 | $133,369,592 | |
| 8 | GSK |
GSK plc
|
2,286,880 | $126,212,906 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $134,849,568 | 683,752 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||